内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Aurinia Pharmaceuticals Inc.

AUPH · Nasdaq · CIK 0001600620 · Healthcare · Biotechnology

内部人信号

53.8 / 100

1 位买方 · 5 条买入交易行 · $12.5M 买入总额

为什么有这个信号？

买方广度较低
买入规模较强
角色中等
近期性较低
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+23.2 / 25
角色+13.0 / 20
近期性+1.0 / 10
确信度+9.6 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ 角色得分低 · 买入者中职位最高的是：Chief Executive Officer（CEO、董事长和持股 10% 以上的股东得分最低）
  • ⚠ Purchase activity is becoming less recent

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
TANG CAPITAL MANAGEMENT LLC; TANG KEVINChief Executive Officer
●●●
Robertson Stephen P.Chief Legal Officer
○▼▼
Hearne Michael SChief Financial Officer
○
Cole RyanChief Operating Officer
○
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方1
买入集中度100%最大买方： TANG CAPITAL MANAGEMENT LLC; TANG KEVIN · $12.5M
聚集买入 · 15天1 insider峰值活动： 2026-05-29–2026-06-02

Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

53.8 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 53.9
  2. 53.9
  3. 53.9
  4. 53.8
  5. 53.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

11买入
2卖出
28其他 Form 4 交易行
24SEC 申报 · 365天
买入5 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他3 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
+3.4%
3M
+3.9%
6M
+5.6%
12M
+44.4%

波动率与流动性

波动率
43.2%
Beta
—
平均每日成交额
USD 16.1M

估值

市值
—
P/E
—

基本面

利润率
101.5%
ROE
49.4%
细分行业
Biotechnology

市场数据

价格数据截至：2026-10-09 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
7,920,606
上期报告
8,576,505
日均成交量
844,517
回补天数
9.4

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-02TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares206,005USD 15.28USD 3,147,756SEC 申报 ↗
2026-06-01TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares343,620USD 15.28USD 5,250,520SEC 申报 ↗
2026-05-29TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares264,981USD 15.31USD 4,056,951SEC 申报 ↗
2026-03-03TANG KEVIN买入 (P)Common Shares184,208USD 14.22USD 2,619,438SEC 申报 ↗
2026-03-02TANG KEVIN买入 (P)Common Shares199,353USD 14.26USD 2,842,833SEC 申报 ↗
2026-02-27TANG KEVIN买入 (P)Common Shares516,439USD 13.99USD 7,226,535SEC 申报 ↗
2025-08-05TANG KEVIN买入 (P)Common Shares200,000USD 11.68USD 2,336,000SEC 申报 ↗
2025-08-04TANG KEVIN买入 (P)Common Shares100,000USD 11.34USD 1,134,000SEC 申报 ↗
2025-08-01TANG KEVIN买入 (P)Common Shares1,000,000USD 10.12USD 10,120,000SEC 申报 ↗
2025-03-04TANG KEVIN买入 (P)Common Shares748,038USD 7.96USD 5,953,304SEC 申报 ↗
2025-03-03TANG KEVIN买入 (P)Common Shares452,682USD 8.01USD 3,625,474SEC 申报 ↗
2025-02-28TANG KEVIN买入 (P)Common Shares399,280USD 7.85USD 3,134,348SEC 申报 ↗
2024-12-09TANG KEVIN买入 (P)Common Shares500,000USD 9.09USD 4,545,000SEC 申报 ↗
2024-12-06TANG KEVIN买入 (P)Common Shares400,000USD 9.01USD 3,604,000SEC 申报 ↗
2024-12-05TANG KEVIN买入 (P)Common Shares300,000USD 8.91USD 2,673,000SEC 申报 ↗

Form 4 申报证据

41 transaction lines in the latest 365-day window; 228 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-10Robertson Stephen P.卖出 (S)Common Stock11,939USD 15.95USD 190,427SEC 申报 ↗
2026-08-21Robertson Stephen P.卖出 (S)Common Stock20,975USD 16.97USD 355,946SEC 申报 ↗
2026-06-02TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares206,005USD 15.28USD 3,147,756SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-10Robertson Stephen P.卖出 (S)Common Stock11,939USD 15.95USD 190,427SEC 申报 ↗
2026-08-21Robertson Stephen P.卖出 (S)Common Stock20,975USD 16.97USD 355,946SEC 申报 ↗
2026-06-02TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares206,005USD 15.28USD 3,147,756SEC 申报 ↗
2026-06-01TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares343,620USD 15.28USD 5,250,520SEC 申报 ↗
2026-05-29TANG CAPITAL MANAGEMENT LLC; TANG KEVIN买入 (P)Common Shares264,981USD 15.31USD 4,056,951SEC 申报 ↗
2026-05-18Robertson Stephen P.奖励／授予 (A)Common Stock115,541USD 0.00USD 0SEC 申报 ↗
2026-05-18Hearne Michael S奖励／授予 (A)Common Stock116,144USD 0.00USD 0SEC 申报 ↗
2026-05-18Cole Ryan奖励／授予 (A)Common Stock116,144USD 0.00USD 0SEC 申报 ↗
2026-03-06Keenan Greg代扣税 (F)Common Stock8,069USD 14.32USD 115,548SEC 申报 ↗
2026-03-03TANG KEVIN买入 (P)Common Shares184,208USD 14.22USD 2,619,438SEC 申报 ↗
2026-03-02TANG KEVIN买入 (P)Common Shares199,353USD 14.26USD 2,842,833SEC 申报 ↗
2026-03-02Robertson Stephen P.代扣税 (F)Common Stock36,525USD 14.21USD 519,020SEC 申报 ↗
2026-03-02Miller Joseph M代扣税 (F)Common Stock37,511USD 14.21USD 533,031SEC 申报 ↗
2026-03-02Greenleaf Peter代扣税 (F)Common Stock100,890USD 14.21USD 1,433,647SEC 申报 ↗
2026-03-02Donley Matthew Maxwell代扣税 (F)Common Stock40,761USD 14.21USD 579,214SEC 申报 ↗
2026-02-27TANG KEVIN买入 (P)Common Shares516,439USD 13.99USD 7,226,535SEC 申报 ↗
2026-02-27Robertson Stephen P.奖励／授予 (A)Common Stock59,090USD 0.00USD 0SEC 申报 ↗
2026-02-27Miller Joseph M奖励／授予 (A)Common Stock57,229USD 0.00USD 0SEC 申报 ↗
2026-02-27Keenan Greg奖励／授予 (A)Common Stock40,586USD 0.00USD 0SEC 申报 ↗
2026-02-27Greenleaf Peter奖励／授予 (A)Common Stock196,403USD 0.00USD 0SEC 申报 ↗
2026-02-27Donley Matthew Maxwell奖励／授予 (A)Common Stock58,160USD 0.00USD 0SEC 申报 ↗
2026-02-20Robertson Stephen P.代扣税 (F)Common Stock34,638USD 14.40USD 498,787SEC 申报 ↗
2026-02-20Miller Joseph M代扣税 (F)Common Stock32,424USD 14.40USD 466,906SEC 申报 ↗
2026-02-20Greenleaf Peter代扣税 (F)Common Stock100,171USD 14.40USD 1,442,462SEC 申报 ↗
2026-02-20Donley Matthew Maxwell代扣税 (F)Common Stock32,901USD 14.40USD 473,774SEC 申报 ↗
2026-02-02Keenan Greg代扣税 (F)Common Stock11,552USD 14.53USD 167,851SEC 申报 ↗
2026-01-02Robertson Stephen P.代扣税 (F)Common Stock40,385USD 15.95USD 644,141SEC 申报 ↗
2026-01-02Robertson Stephen P.奖励／授予 (A)Common Stock48,558USD 0.00USD 0SEC 申报 ↗
2026-01-02Miller Joseph M代扣税 (F)Common Stock40,161USD 15.95USD 640,568SEC 申报 ↗
2026-01-02Miller Joseph M奖励／授予 (A)Common Stock49,038USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码AUPH
CIK0001600620
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史228 transaction lines from 2021-01-28 to 2026-09-10
43 P purchase lines · 83 S sale lines · 102 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.